Alpha Cognition (NASDAQ:ACOG – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.48) by ($0.03), Zacks reports.
Alpha Cognition Trading Down 8.5 %
Alpha Cognition stock opened at $5.06 on Tuesday. The stock has a market capitalization of $81.06 million, a price-to-earnings ratio of -1.98 and a beta of 2.50. Alpha Cognition has a 1-year low of $4.66 and a 1-year high of $7.00. The business’s 50-day moving average price is $5.83.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on the company. Raymond James upgraded Alpha Cognition to a “moderate buy” rating in a report on Tuesday, March 25th. HC Wainwright reiterated a “buy” rating and issued a $20.00 price objective on shares of Alpha Cognition in a research report on Monday.
Alpha Cognition Company Profile
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Featured Stories
- Five stocks we like better than Alpha Cognition
- Following Congress Stock Trades
- Amprius Market Gets Amped Up on Growth Outlook
- How to Calculate Return on Investment (ROI)
- ETFs With the Best Returns of 2025: Gold and Silver Miners on Top
- Market Cap Calculator: How to Calculate Market Cap
- Paychex and Cintas Show Surprising Labor Market Resilience
Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
